• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

详细的 HIV-1 蛋白酶界面的原子分析。

Detailed atomistic analysis of the HIV-1 protease interface.

机构信息

REQUIMTE, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto, Porto, Portugal.

出版信息

J Phys Chem B. 2011 Jun 2;115(21):7045-57. doi: 10.1021/jp200075s. Epub 2011 May 5.

DOI:10.1021/jp200075s
PMID:21545127
Abstract

HIV-1 protease is a very attractive target for the development of new anti-HIV drugs and has been extensively studied over the past decades. In this study, we present a detailed atomic level characterization of the dimer interface in the enzyme HIV-1 protease through computational alanine scanning mutagenesis and molecular dynamics simulations. In addition to a full mapping of the amino acid residues present at the subunit interface, in terms of the corresponding energetic contribution for dimer formation and of their classification as hot spots, warm spots, and null spots, we trace a dynamic analysis of the subunit interacting and solvent accessible surface areas and of the most important hydrogen bonds between subunits. The results presented illustrate the high energetic importance for dimer formation of a small set of five amino acid residue pairs at the subunit interface-Leu5, Ile50, Arg87, Leu97, and Phe99-and provide important clues on the most important structural and energetic determinants for dimer formation. In addition, the results presented suggest several key targets at the subunit interface for the development of new molecules that aim to inhibit HIV-1 protease (PR) activity through blocking the formation of the fully active PR homodimeric form, providing important clues for drug design.

摘要

HIV-1 蛋白酶是开发新型抗 HIV 药物的极具吸引力的靶标,在过去几十年中得到了广泛的研究。在这项研究中,我们通过计算丙氨酸扫描突变和分子动力学模拟,对 HIV-1 蛋白酶酶中二聚体界面进行了详细的原子水平表征。除了全面绘制亚基界面上存在的氨基酸残基图谱,包括它们对二聚体形成的相应能量贡献以及它们作为热点、暖点和冷点的分类外,我们还对亚基相互作用和溶剂可及表面积以及亚基之间最重要的氢键进行了动态分析。所呈现的结果说明了在亚基界面上的一小部分五个氨基酸残基对(Leu5、Ile50、Arg87、Leu97 和 Phe99)对二聚体形成具有很高的能量重要性,并为二聚体形成的最重要的结构和能量决定因素提供了重要线索。此外,所呈现的结果表明在亚基界面上有几个关键靶点,可以开发新的分子,旨在通过阻止完全活性的 PR 同源二聚体形式的形成来抑制 HIV-1 蛋白酶(PR)活性,为药物设计提供了重要线索。

相似文献

1
Detailed atomistic analysis of the HIV-1 protease interface.详细的 HIV-1 蛋白酶界面的原子分析。
J Phys Chem B. 2011 Jun 2;115(21):7045-57. doi: 10.1021/jp200075s. Epub 2011 May 5.
2
Detection of farnesyltransferase interface hot spots through computational alanine scanning mutagenesis.通过计算丙氨酸扫描突变检测法来发现法呢基转移酶界面热点。
J Phys Chem B. 2011 Dec 29;115(51):15339-54. doi: 10.1021/jp205481y. Epub 2011 Dec 2.
3
The structural stability of the HIV-1 protease.HIV-1蛋白酶的结构稳定性。
J Mol Biol. 1998 Oct 23;283(2):475-88. doi: 10.1006/jmbi.1998.2090.
4
The folding and dimerization of HIV-1 protease: evidence for a stable monomer from simulations.HIV-1蛋白酶的折叠与二聚化:模拟得出的稳定单体证据
J Mol Biol. 2004 Jun 25;340(1):67-79. doi: 10.1016/j.jmb.2004.04.028.
5
Structure, dynamics and solvation of HIV-1 protease/saquinavir complex in aqueous solution and their contributions to drug resistance: molecular dynamic simulations.HIV-1蛋白酶/沙奎那韦复合物在水溶液中的结构、动力学和溶剂化作用及其对耐药性的影响:分子动力学模拟
J Chem Inf Model. 2005 Mar-Apr;45(2):300-8. doi: 10.1021/ci049784g.
6
Structural and energetic analysis on the complexes of clinically isolated subtype C HIV-1 proteases and approved inhibitors by molecular dynamics simulation.通过分子动力学模拟对临床分离的 C 型 HIV-1 蛋白酶和已批准抑制剂复合物的结构和能量分析。
J Phys Chem B. 2010 Jan 14;114(1):521-30. doi: 10.1021/jp908314f.
7
Free energy calculations on dimer stability of the HIV protease using molecular dynamics and a continuum solvent model.使用分子动力学和连续溶剂模型对HIV蛋白酶二聚体稳定性进行的自由能计算。
J Mol Biol. 2000 Nov 3;303(4):567-82. doi: 10.1006/jmbi.2000.4057.
8
Efficiency of a second-generation HIV-1 protease inhibitor studied by molecular dynamics and absolute binding free energy calculations.通过分子动力学和绝对结合自由能计算研究第二代HIV-1蛋白酶抑制剂的效率。
Proteins. 2004 Nov 1;57(2):279-93. doi: 10.1002/prot.20192.
9
Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis.对HIV-1蛋白酶活性位点苏氨酸的系统性突变分析:重新审视“消防员握法”假说。
Protein Sci. 2000 Sep;9(9):1631-41. doi: 10.1110/ps.9.9.1631.
10
Structure-based design of carbon nanotubes as HIV-1 protease inhibitors: atomistic and coarse-grained simulations.基于结构的碳纳米管作为 HIV-1 蛋白酶抑制剂的设计:原子和粗粒模拟。
J Mol Graph Model. 2010 Sep;29(2):171-7. doi: 10.1016/j.jmgm.2010.05.009. Epub 2010 May 27.

引用本文的文献

1
Toll-like receptor-guided therapeutic intervention of human cancers: molecular and immunological perspectives. Toll 样受体导向的人类癌症治疗干预:分子和免疫学观点。
Front Immunol. 2023 Sep 26;14:1244345. doi: 10.3389/fimmu.2023.1244345. eCollection 2023.
2
Molecular dynamics simulations reveal the selectivity mechanism of structurally similar agonists to TLR7 and TLR8.分子动力学模拟揭示了结构相似激动剂对 TLR7 和 TLR8 的选择性作用机制。
PLoS One. 2022 Apr 22;17(4):e0260565. doi: 10.1371/journal.pone.0260565. eCollection 2022.
3
Oligomerization engineering of the fluorinase enzyme leads to an active trimer that supports synthesis of fluorometabolites in vitro.
氟酶的寡聚化工程导致了活性三聚体的产生,该三聚体支持氟代谢物的体外合成。
Microb Biotechnol. 2022 May;15(5):1622-1632. doi: 10.1111/1751-7915.14009. Epub 2022 Jan 27.
4
The importance of physicochemical characteristics and nonlinear classifiers in determining HIV-1 protease specificity.物理化学特性和非线性分类器在确定HIV-1蛋白酶特异性中的重要性。
Bioengineered. 2016 Apr 2;7(2):65-78. doi: 10.1080/21655979.2016.1149271.
5
Understanding the molecular basis of EGFR kinase domain/MIG-6 peptide recognition complex using computational analyses.利用计算分析理解表皮生长因子受体(EGFR)激酶结构域/MIG-6肽识别复合物的分子基础。
BMC Bioinformatics. 2015 Mar 27;16:103. doi: 10.1186/s12859-015-0528-x.
6
Discovery of new druggable sites in the anti-cholesterol target HMG-CoA reductase by computational alanine scanning mutagenesis.通过计算丙氨酸扫描诱变在抗胆固醇靶点HMG-CoA还原酶中发现新的可成药位点。
J Mol Model. 2014 Apr;20(4):2178. doi: 10.1007/s00894-014-2178-8. Epub 2014 Mar 27.